title: Biotech's next big blowup?
authors.forename: David
authors.initials: D
authors.lastname: Stires
mesh_terms: D001709:Biotechnology; D017326:Clinical Trials, Phase III as Topic; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D016527:Drug Costs; D004345:Drug Industry / Q000191:economics* / Q000331:legislation & jurisprudence; D006801:Humans; D007371:Interferon-gamma / Q000191:economics / Q000627:therapeutic use*; D007449:Investments; D011658:Pulmonary Fibrosis / Q000188:drug therapy*; D011994:Recombinant Proteins; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D011994:Recombinant Proteins; D007371:Interferon-gamma